PDF(481 KB)
《2024年亚太肝病学会推荐意见:非肝硬化门静脉纤维化/特发性门静脉高压的诊断和管理》摘译
夏俊琪, 吕哲, 刘成海, 祁兴顺
PDF(481 KB)
PDF(481 KB)
《2024年亚太肝病学会推荐意见:非肝硬化门静脉纤维化/特发性门静脉高压的诊断和管理》摘译
An excerpt of non‑cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management (2024)
,
近期,亚太肝病学会发布了有关非肝硬化门静脉纤维化(NCPF)/特发性门静脉高压(IPH)诊断和管理的推荐意见。该指南主要围绕NCPF/IPH的定义、诊断、组织学特征、自然病史和管理等方面进行了系统阐述,旨在加强当前对NCPF/IPH相关问题的理解,并建立全球共识。本文对指南中的重要声明进行摘译。
Recently, Asian Pacific Association for the Study of the Liver published the recommendations for the diagnosis and management of non-cirrhotic portal fibrosis (NCPF)/idiopathic portal hypertension (IPH). The guidelines mainly elaborate on the definition, diagnosis, histological features, natural history, and management of NCPF/IPH, in order to strengthen the understanding of NCPF/IPH-related issues and establish a global consensus. This article makes an excerpt of the key statements in the guidelines.
Liver Diseases / Fibrosis / Hypertension, Portal / Practice Guidelines
| 1 |
|
夏俊琪、吕哲负责翻译,对本文贡献等同,为共同第一作者;刘成海、祁兴顺负责审校。
/
| 〈 |
|
〉 |